MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

AbbVie

  1. Home
  2. Companies
  3. AbbVie
  4. Clinical Trials

Clinical Trials Related to AbbVie

Related studies linked through entity extraction aliases.

NCT00654758

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Status
COMPLETED
Phase
PHASE1

NCT00650156

Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis

Status
COMPLETED
Phase
PHASE1

NCT00619866

An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis

Status
COMPLETED
Phase
PHASE2

NCT00526617

A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients

Status
COMPLETED
Phase
PHASE1

NCT00481091

A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT00437658

Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis

Status
COMPLETED
Phase
PHASE2

NCT00404989

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

Status
RECRUITING
Phase
N/A

NCT00390221

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis

Status
COMPLETED
Phase
PHASE2

NCT00114114

Dose-Response of Gonadal Steroids and Bone Turnover in Older Men

Status
COMPLETED
Phase
NA
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.